share_log

Benchmark Maintains Buy on HNI, Raises Price Target to $45

Benzinga ·  Aug 9, 2023 11:21

Benchmark analyst Reuben Garner maintains HNI (NYSE:HNI) with a Buy and raises the price target from $36 to $45.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment